Darciane F. Baggio,* Fernanda M.R. da Luz,* Raphael V. Lopes,* Luiz E.N. Ferreira,y Erika I. Araya,z and Juliana G. Chichorro
doi : 10.1016/j.jpain.2022.12.013
Volume 24, Issue 5, May 2023, Pages 717-729
Resolvin D5 (RvD5) is a specialized pro-resolving lipid mediator with potent anti-inflammatory and analgesic properties. Orofacial pain conditions, especially those that are chronic, present clinical challenges in terms of pharmacological management. Thus, new therapeutic options are clearly warranted.
Yo-Jen Liao,* Ying-Ling Jao,* Diane Berish,* Angelina Seda Hin,y Karolus Wangi,* Lisa Kitko,* Jacqueline Mogle,z and Marie Boltz
doi : 10.1016/j.jpain.2022.12.014
Volume 24, Issue 5, May 2023, Pages 730-741
Approximately 50% of persons living with dementia experience pain, yet it is frequently undetected and inadequately managed resulting in adverse consequences. This review aims to synthesize evidence on the barriers and facilitators of pain management in persons living with dementia.
Elizabeth S. Goldsmith,*,y Wendy A. Miller,* ,y Erin Koffel,* Kristen Ullman,*,z Adrienne Landsteiner,*,z Benjamin Stroebel, # Jessica Hill,�� Princess E. Ackland,*,y Timothy J. Wilt,*,y,z,x and Wei Duan-Porter
doi : 10.1016/j.jpain.2023.02.026
Volume 24, Issue 5, May 2023, Pages 742-769
Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and mindfulness-based stress reduction (MBSR) have demonstrated effectiveness for improving outcomes in chronic pain.
Felicia TA Sundstr€om, Amani Lavefjord, Monica Buhrman, and Lance M McCracken
doi : 10.1016/j.jpain.2022.11.010
Volume 24, Issue 5, May 2023, Pages 770-781
Psychological flexibility (PF) is a model of well-being and daily functioning that is applied to chronic pain, and is the model behind Acceptance and Commitment Therapy (ACT). However, studies of PF in chronic pain are limited by the lack of a single measure capturing all facets.
Abbie Suttle,* Peng Wang,* Fabiana C. Dias,* Qiaojuan Zhang,* Yuhui Luo,* Lauren Simmons,* Andrey Bortsov,y Inna E. Tchivileva,z Andrea G. Nackley,y,x and Yong Chen
doi : 10.1016/j.jpain.2022.12.001
Volume 24, Issue 5, May 2023, Pages 782-795
Temporomandibular disorder (TMD) pain that involves inflammation and injury in the temporomandibular joint (TMJ) and/or masticatory muscle is the most common form of orofacial pain.
Najah Alhajri, Shellie Ann Boudreau, and Thomas Graven-Nielsen
doi : 10.1016/j.jpain.2022.12.004
Volume 24, Issue 5, May 2023, Pages 796-811
Prolonged experimental pain models can help assess cortical mechanisms underlying the transition from acute to chronic pain such as resting-state functional connectivity (rsFC), especially in early stages.
Jordi Miro,* ,y Josep Roman-Juan,*,y Elisabet Sanchez-Rodrıguez,*,y Ester Sole,*,y Elena Castarlenas,*,y and Mark P. Jensen
doi : 10.1016/j.jpain.2022.12.007
Volume 24, Issue 5, May 2023, Pages 812-823
The aims of this study were to: 1) estimate the prevalence of chronic pain (CP) and high impact chronic pain (HICP) in a community sample of children and adolescents; and 2) compare groups (those without CP, those with CP but no HICP, and those with HICP) with respect to demographic variables, pain variables, and physical, psychological, and school-related function
Rodrigo R.N. Rizzo,* ,y Benedict M. Wand,z Hayley B Leake,y,x Edel T. O’Hagan,y,{,║ Matthew K. Bagg,y, ** Samantha Bunzli,yy,zz Adrian C. Traeger,xx Sylvia M. Gustin,y,{{ G. Lorimer Moseley,x Saurab Sharma,*,y Aidan G. Cashin,*,y and James H. McAuley
doi : 10.1016/j.jpain.2022.12.009
Volume 24, Issue 5, May 2023, Pages 824-839
A new wave of treatments has emerged to target nervous system alterations and maladaptive conceptualizations about pain for chronic low back pain. The acceptability of these treatments is still uncertain.
Biao Xu, Run Zhang, Mengna Zhang, Dan Chen, Qinqin Zhang, Nan Zhang, Yonghang Shi, Xuanran Hu, Ning Li, and Quan Fang
doi : 10.1016/j.jpain.2022.12.012
Volume 24, Issue 5, May 2023, Pages 840-859
Venom-derived NaV1.7 channel blockers have promising prospects in pain management. The 34-residue tarantula peptide GpTx-1 is a potent NaV1.7 channel blocker. Its powerful analog [Ala5, Phe6, Leu26, Arg28]GpTx-1 (GpTx-1-71) displayed excellent NaV1.7 selectivity and analgesic properties in mice.
Trevor A. Lentz,* ,y,z Jonathan Gonzalez-Smith,z Katie Huber,z Christine Goertz,*,y,z William K. Bleser,z and Robert Saunders
doi : 10.1016/j.jpain.2022.12.015
Volume 24, Issue 5, May 2023, Pages 860-873
Integrated pain management (IPM) programs can help to reduce the substantial population health burden of musculoskeletal pain, but are poorly implemented. Lessons learned from existing programs can inform efforts to expand IPM implementation.
Elsa Cisneros,y,1 Anabel Martınez-Padilla,z,1 Casimiro Cardenas,z,x Javier Marquez,z Arantxa Ortega de Mues, # and Carolina Roza
doi : 10.1016/j.jpain.2023.01.001
Volume 24, Issue 5, May 2023, Pages 874-887
Chronic visceral pain (CVP) is extremely difficult to diagnose, and available analgesic treatment options are quite limited. Identifying the proteins secreted from the colonic nociceptors, or their neighbor cells within the tube walls, in the context of disorders that course with visceral pain, might be useful to decipher the mechanism involved in the establishment of CVP.
Elisa Kamper-Fuhrmann, Alexander Winkler, Alannah Hahn, and Christiane Hermann
doi : 10.1016/j.jpain.2022.12.010
Volume 24, Issue 5, May 2023, Pages 888-900
The method-of-limits (MLI) is an established psychophysical procedure, for example for determining thermal thresholds. The standard MLI relies on fixating the thermode at the stimulation site by means of a strap and requires the participant to terminate the increase in heat by pressing a button.
doi : 10.1016/j.jpain.2023.01.005
Volume 24, Issue 5, May 2023, Pages 901-917
The method-of-limits (MLI) is an established psychophysical procedure, for example for determining thermal thresholds. The standard MLI relies on fixating the thermode at the stimulation site by means of a strap and requires the participant to terminate the increase in heat by pressing a button.
doi : 10.1016/S1526-5900(23)00390-5
Volume 24, Issue 5, May 2023, Pages 918-920
Do you want to add Medilib to your home screen?